Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dosimetry”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT04168528
What this trial is testing

Phase I/IIa Study of 68GaNOTA-Anti-MMR-VHH2 for PET/CT

Who this might be right for
Malignant Solid TumorBreast CancerMelanoma (Skin)
Universitair Ziekenhuis Brussel 13
Not applicableStudy completedNCT02407977
What this trial is testing

Real Time In-Vivo Body Surface Dosimetry for External Beam Radiation Therapy

Who this might be right for
Cancer of the Gastrointestinal, Genitourinary or Gynecologic Systems
Duke University 13
Not applicableEnded earlyNCT02294981
What this trial is testing

Excimer Laser Phototherapy Outcomes in the Treatment of Psoriasis

Who this might be right for
Psoriasis
University of California, San Francisco 4
Not applicableUnknownNCT05258383
What this trial is testing

Personalized Estimation of Doses Delivered During Image Guided Radiation Therapy Tests

Who this might be right for
Lung NeoplasmPelvic NeoplasmBreast Cancer+2 more
Assistance Publique - Hôpitaux de Paris 320
Not applicableEnded earlyNCT02704312
What this trial is testing

Dosimetric Comparison of Doses in Both Positions (Prone and Decubitus) for Patient With Breast Cancer

Who this might be right for
Breast Cancer
University Hospital Center of Martinique 11
Early research (Phase 1)Study completedNCT00925275
What this trial is testing

Dosimetry Study of I-131-CLR1404 in Patients With Relapsed or Refractory Advanced Solid Tumors

Who this might be right for
Solid Tumors
Cellectar, Inc 9